Clinical Trial

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Study acronym: SASS
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-11-19; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2020-01-23
Trial Details
NCT Number NCT04171661
Lead Sponsor CHU de Quebec-Universite Laval
Collaborators: The Hospital for Sick Children
Conditions Epidermolysis Bullosa Dystrophica
Enrollment 1 participants
Start Date 2019-12-10
Primary Completion 2019-12-24 (estimated)
Study Completion 2026-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-03-19